用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Horizon Pharma Usa, Inc.(23)
HORIZON THERAPEUTICS INC [US](16)
RICHTER GEDEON VEGYESZET [HU](12)
MCNEIL PPC INC [US](9)
MARGA INVESTIGACION [ES](9)
YAMANOUCHI PHARMA CO LTD [JP](8)
Richter Gedeon Vegyeszeti Gyar R.t.(7)
Richter Gedeon Vegyeszeti Gyar Rt.(7)
Richter Gedeon V G Rt(6)
ASTELLAS PHARMA INC.(6)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Famotidine '
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
上页
1
2
3
4
5
6
7
8
下页
尾页
共
354
条记录, 当前第3/36页。
公开号
公开日
申请号
申请日
1.
US2013011476A1
2013/1/10
US201213620150
2012/9/14
专利标题
:STABLE COMPOSITIONS OF FAMOTIDINE AND IBUPROFEN
专利权人
:
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine.
2.
US2013011475A1
2013/1/10
US201213620141
2012/9/14
专利标题
:STABLE COMPOSITIONS OF FAMOTIDINE AND IBUPROFEN
专利权人
:
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine.
3.
US20130011475A1
2013/1/10
US13/620141
2012/9/14
专利标题
:Stable compositions of famotidine and ibuprofen
专利权人
:
Horizon Pharma Usa, Inc.
;
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.
4.
US20130011476A1
2013/1/10
US13/620150
2012/9/14
专利标题
:Stable compositions of famotidine and ibuprofen
专利权人
:
Horizon Pharma Usa, Inc.
;
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.
5.
WO2012173581A1
2012/12/20
WO2012TR00053
2012/3/21
专利标题
:THIOCOLCHICOSIDE, ETODOLAC AND FAMOTIDINE COMBINATIONS
专利权人
:
KIMYA ITHALAT IHRACAT VE SANAYII A S AK [TR]
;
PISAK IBRAHIM MUSTAFA ISKENDER [TR]
;
SELAMOGLU MEHMET LEVENT [TR]
;
BINGOL SEMRA [TR]
;
The present invention relates to the unit dosage forms comprising a. thiocolchicoside or a pharmaceutically acceptable salt thereof or any therapeutically active optically pure stereoisomer thereof as a muscle relaxant, b. etodolac or a pharmaceutically acceptable salt thereof or any therapeutically active optically pure stereoisomer thereof as an NSAID, and c. famotidine or a pharmaceutically acceptable salt thereof as a gastroprotectant.
6.
US8318202B2
2012/11/27
US13/403930
2012/2/23
专利标题
:Stable compositions of famotidine and ibuprofen
专利权人
:
Horizon Pharma Usa, Inc.
;
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.
7.
US8309127B2
2012/11/13
US13/403923
2012/2/23
专利标题
:Stable compositions of famotidine and ibuprofen
专利权人
:
Horizon Pharma Usa, Inc.
;
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.
8.
CN101380313B
2012/11/7
CN20081228113
2008/10/16
专利标题
:Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof
专利权人
:
Shenyang Pharmaceutical University
;
9.
CN101516368B
2012/10/3
CN20078034493
2007/7/17
专利标题
:The method and the medicine that are used for administration of ibuprofen
专利权人
:
Horizon Therapeutics Inc.
;
10.
KR20120094253A
2012/8/24
KR20110013635
2011/2/16
专利标题
:Multi layer pharmaceutical tablet with improved stability comprising sulglycotide and h2 antagonists and preparation method thereof
专利权人
:
Samil Pharmaceutical Co., Ltd.
;
PURPOSE: A stability improved sulglycotide a multi-layer tablet and a manufacturing method thereof are provided to have better damaged stomach protection effects than respectively administrating the sulglycotide and a H2 receptor antagonist. CONSTITUTION: A pharmaceutical composition for treating or preventing gastrointestinal disorder comprises sulglycotide and H2 receptor antagonist as active ingredients. The H2 receptor antagonist is nizatidine ranitidine famotidine cimetidine or lafutidine. ...
首页
上页
1
2
3
4
5
6
7
8
下页
尾页
共
354
条记录, 当前第3/36页。
当前查询条件: [药品] 包含 'Famotidine '
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文